Discover 468 paid clinical trials in Grand Rapids, Michigan. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 468
Phase III Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as First-line Treatment of Hepatocellular Carcinoma
for
Hepatocellular Carcinoma
Location: Grand Rapids MI, Milwaukee WI, Detroit MI, Chicago IL,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT06921785
Phase 3, Recruiting
A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
for
Chronic Obstructive Pulmonary Disease (COPD)
Location: Grand Rapids MI, Farmington Hills MI, Garden City MI,
Sponsor: AstraZeneca
Sex: All
Age: 40+
Code: NCT07082738
Phase 2, Recruiting
A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors
for
Melanoma, Non-small Cell Lung Cancer,
Location: Grand Rapids MI, Pittsburgh PA, St Louis MO, Fairfax VA,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT07115043
Phase 1, Phase 2, Recruiting
Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
for
Endometrial Cancer, Gastric Cancer,
Location: Grand Rapids MI, Madison WI, Columbus OH, Cincinnati OH,
Sponsor: AstraZeneca
Sex: All
Age: 18 - 70+
Code: NCT05489211
Phase 2, Recruiting
Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations
for
Non-Small Cell Lung Cancer
Location: Grand Rapids MI, Farmington Hills MI, Dearborn MI,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT06357533
Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Non-Squamous NSCLC
for
Non-squamous Non-small Cell Lung Cancer
Location: Grand Rapids MI, Chicago IL, Hinsdale IL,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT06627647
Phase 3, Recruiting
Targeted Alpha-Particle Therapy for Advanced Somatostatin Receptor Type 2 (SSTR2) Positive Tumors
for
Neuroendocrine Tumors Unresectable,
Location: Grand Rapids MI, Milwaukee WI, Chicago IL, Troy MI,
Sponsor: Perspective Therapeutics
Sex: All
Age: 18 - 70+
Code: NCT05636618
Phase 1, Phase 2, Recruiting
64Cu-LNTH-1363S in Patients With Sarcoma or Gastrointestinal Tract Cancer
Location: Grand Rapids MI, Toronto, Rochester MN, Montreal,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 18 - 70+
Code: NCT06562192
Phase 1, Recruiting
64Cu-SAR-bisPSMA and 67Cu-SAR-bisPSMA for Identification and Treatment of PSMA-expressing Metastatic Castrate Resistant Prostate Cancer (SECuRE)
for
Prostatic Neoplasms, Castration-Resistant
Location: Grand Rapids MI, Rochester MN, St Louis MO, Omaha NE,
Sponsor: Clarity Pharmaceuticals Ltd
Sex: Male
Age: 18+
Code: NCT04868604
Phase 1, Phase 2, Recruiting
Dose Optimization and Diagnostic Performance in Prostate Cancer (SPARROW [Staging Prostate Cancer With Advanced RM2 Radiotracer Oncologic Workup])
for
Prostate Cancer
Location: Grand Rapids MI
Sponsor: Lantheus Medical Imaging
Sex: Male
Age: 18+
Code: NCT07831824
Phase 2, Phase 3, Recruiting
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
for
Ovarian Neoplasms, Breast Neoplasms,
Location: Grand Rapids MI, Detroit MI, Madison WI,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT07213791
Phase 1, Recruiting
A Study of [225Ac]Ac-AKY-1189 in Patients With Solid Tumors
for
Urothelial Carcinoma Bladder,
Location: Grand Rapids MI, Iowa City IA, Pittsburgh PA,
Sponsor: Aktis Oncology, Inc.
Sex: All
Age: 18+
Code: NCT07020117
Phase 1, Recruiting
Michigan Contraceptive Access, Research, and Evaluation Study Children: Phase 1
for
Pregnancy
Location: Grand Rapids MI, Kalamazoo MI, Lansing MI, Ann Arbor MI,
Sponsor: University of Michigan
Sex: All
Age: 0 - 17
Code: NCT04371900
Recruiting
ALTO-100 in Bipolar Disorder With Depression (BD-D)
for
Bipolar Disorder I or II With a Major Depressive Episode
Location: Grand Rapids MI, Ann Arbor MI, Chicago IL, Carmel IN,
Sponsor: Alto Neuroscience
Sex: All
Age: 18 - 70
Code: NCT06656416
Phase 2, Recruiting
A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)
for
Diffuse Large B-Cell Lymphoma
Location: Grand Rapids MI, Saginaw MI, Ann Arbor MI,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06717347
Phase 3, Recruiting
A Study of DB-1324 in Advanced/Metastatic Gastrointestinal Tumors
for
Gastrointestinal Cancer
Location: Grand Rapids MI, Cincinnati OH, Huntersville NC,
Sponsor: DualityBio Inc.
Sex: All
Age: 18+
Code: NCT07263594
Phase 1, Phase 2, Recruiting
Multilevel Community-Centered Intervention to Reduce Pregnancy Related and Associated Morbidity and Mortality (PRAMM) Disparities
for
Provider Confidence, Provider Behavior
Location: Grand Rapids MI
Sponsor: Michigan State University
Sex: All
Age: 18+
Code: NCT07025057
Recruiting
CHERL, Connecting Primary Care Patients With Community Resources to Facilitate Behavior Change
for
Tobacco Use Disorder, Alcohol Abuse, Lack of Physical Activity,
Location: Grand Rapids MI, Flint MI, Marquette MI
Sponsor: Great Lakes Research Into Practice Network
Sex: All
Age: 18+
Code: NCT00269009
Phase 1, Recruiting
Evaluation of the PrevisEA Device for Predicting Gastrointestinal Impairment
for
Gastrointestinal Complication
Location: Grand Rapids MI, Chicago IL, Cleveland OH, Rochester MN,